Algernon claimed to be a Phase II clinical trial company.The reality is Algernon still has not launched a real Phase II clinical trial. It has only conducted Phase II "studies" to study if it wants to run a real Phase II clinical trial. The IPF "study" is another nothing burger. Who cares if it's ever fully enrolled? That supposed catalyst sailed by a long time ago. The CEO claims Algernon lost a year with the IPF study. NO! The company as a whole has lost 4 years of dithering around with Private Placements and bogus studies all while the CEO runs around like he's getting things done. It's been a charade up to this point. Malhi made millions and Moreau drove the bus over the cliff AGAIN. Only to then reverse split the stock at all time lows. Now it's a waiting game to see if numb nuts can actually get the uplist to Nasdaq before he begins bleeding you dry with more capital raises. This time last year Moreau put out a nothing burger letter to shareholders thanking them for all their support. Moreau has been a loser for shareholders. It'll take a miracle for his track record in penny world to turn around. The guys a natural born loser.